161 related articles for article (PubMed ID: 12082152)
1. Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts.
Faccio R; Grano M; Colucci S; Villa A; Giannelli G; Quaranta V; Zallone A
J Cell Sci; 2002 Jul; 115(Pt 14):2919-29. PubMed ID: 12082152
[TBL] [Abstract][Full Text] [Related]
2. M-CSF induces the stable interaction of cFms with alphaVbeta3 integrin in osteoclasts.
Elsegood CL; Zhuo Y; Wesolowski GA; Hamilton JA; Rodan GA; Duong LT
Int J Biochem Cell Biol; 2006; 38(9):1518-29. PubMed ID: 16600665
[TBL] [Abstract][Full Text] [Related]
3. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation.
Duong LT; Rodan GA
Front Biosci; 1998 Aug; 3():d757-68. PubMed ID: 9682033
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment.
Pilkington MF; Sims SM; Dixon SJ
J Bone Miner Res; 2001 Jul; 16(7):1237-47. PubMed ID: 11450699
[TBL] [Abstract][Full Text] [Related]
5. Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone.
Nakamura I; Pilkington MF; Lakkakorpi PT; Lipfert L; Sims SM; Dixon SJ; Rodan GA; Duong LT
J Cell Sci; 1999 Nov; 112 ( Pt 22)():3985-93. PubMed ID: 10547359
[TBL] [Abstract][Full Text] [Related]
6. Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro.
Gramoun A; Shorey S; Bashutski JD; Dixon SJ; Sims SM; Heersche JN; Manolson MF
J Cell Biochem; 2007 Oct; 102(2):341-52. PubMed ID: 17390341
[TBL] [Abstract][Full Text] [Related]
7. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
8. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts.
Yaroslavskiy BB; Li Y; Ferguson DJ; Kalla SE; Oakley JI; Blair HC
J Cell Biochem; 2004 Apr; 91(5):962-72. PubMed ID: 15034931
[TBL] [Abstract][Full Text] [Related]
9. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.
Crockett JC; Schütze N; Tosh D; Jatzke S; Duthie A; Jakob F; Rogers MJ
Endocrinology; 2007 Dec; 148(12):5761-8. PubMed ID: 17823253
[TBL] [Abstract][Full Text] [Related]
10. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
11. Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption.
Helfrich MH; Nesbitt SA; Lakkakorpi PT; Barnes MJ; Bodary SC; Shankar G; Mason WT; Mendrick DL; Väänänen HK; Horton MA
Bone; 1996 Oct; 19(4):317-28. PubMed ID: 8894137
[TBL] [Abstract][Full Text] [Related]
12. Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cgamma in prefusion osteoclasts.
Nakamura I; Lipfert L; Rodan GA; Le T Duong
J Cell Biol; 2001 Jan; 152(2):361-73. PubMed ID: 11266452
[TBL] [Abstract][Full Text] [Related]
13. Selective regulation of osteoclast adhesion and spreading by PLCγ/PKCα-PKCδ/RhoA-Rac1 signaling.
Kim JM; Lee K; Jeong D
BMB Rep; 2018 May; 51(5):230-235. PubMed ID: 29301608
[TBL] [Abstract][Full Text] [Related]
14. A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and αvβ3 integrin for osteoporosis therapy.
Zur Y; Rosenfeld L; Keshelman CA; Dalal N; Guterman-Ram G; Orenbuch A; Einav Y; Levaot N; Papo N
PLoS Biol; 2018 Aug; 16(8):e2002979. PubMed ID: 30142160
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.
Chellaiah MA; Kizer N; Biswas R; Alvarez U; Strauss-Schoenberger J; Rifas L; Rittling SR; Denhardt DT; Hruska KA
Mol Biol Cell; 2003 Jan; 14(1):173-89. PubMed ID: 12529435
[TBL] [Abstract][Full Text] [Related]
16. Distinctive and selective route of PI3K/PKCα-PKCδ/RhoA-Rac1 signaling in osteoclastic cell migration.
Kim JM; Kim MY; Lee K; Jeong D
Mol Cell Endocrinol; 2016 Dec; 437():261-267. PubMed ID: 27576187
[TBL] [Abstract][Full Text] [Related]
17. The type II collagen N-propeptide, PIIBNP, inhibits cell survival and bone resorption of osteoclasts via integrin-mediated signaling.
Hayashi S; Wang Z; Bryan J; Kobayashi C; Faccio R; Sandell LJ
Bone; 2011 Oct; 49(4):644-52. PubMed ID: 21708300
[TBL] [Abstract][Full Text] [Related]
18. Linarin and its aglycone acacetin abrogate actin ring formation and focal contact to bone matrix of bone-resorbing osteoclasts through inhibition of αvβ3 integrin and core-linked CD44.
Kim SI; Kim YH; Kang BG; Kang MK; Lee EJ; Kim DY; Oh H; Oh SY; Na W; Lim SS; Kang YH
Phytomedicine; 2020 Dec; 79():153351. PubMed ID: 32987362
[TBL] [Abstract][Full Text] [Related]
19. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanism of osteoclast activation.
Nakamura I; Rodan GA; Duong LT
J Electron Microsc (Tokyo); 2003; 52(6):527-33. PubMed ID: 14756240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
